Transaction | Address | Amount |
---|---|---|
333a87...a3d11b
|
the-void |
+
0.00002035 LTC
·
0.00 USD
|
c5cb4a...206534
|
ltc1qa...w2hxjn
|
-
0.791042 LTC
·
95.00 USD
|
c5cb4a...206534
|
ltc1q0...mvfqg9
|
+
0.790712 LTC
·
94.96 USD
|
c5cb4a...206534
|
the-void |
+
0.00033 LTC
·
0.03 USD
|
554e7c...0d60df
|
ltc1qj...0tms0u
|
-
5.70650588 LTC
·
685.35 USD
|
554e7c...0d60df
|
LN2TpH...cXRPim
|
+
0.014 LTC
·
1.68 USD
|
554e7c...0d60df
|
ltc1q2...kzsscz
|
+
5.692361 LTC
·
683.65 USD
|
554e7c...0d60df
|
the-void |
+
0.00014488 LTC
·
0.01 USD
|
dde903...91b0d2
|
LbZ9uc...Yn2eWU
|
-
4.6193063 LTC
·
554.77 USD
|
dde903...91b0d2
|
Lbeqxh...d3d1yp
|
+
0.06820413 LTC
·
8.19 USD
|
Exploring DeSoc's potential for higher returns compared to Litecoin, Monero, and AVAX.
As July ends, investors debate whether DeSoc, Litecoin, or XRP offers the best investment potential. Litecoin surged with a $100 million move by MEI Pharma, while XRP's rise is fueled by new institutional confidence.
DeSoc’s presale exceeds $10 million, aiming to challenge Dogecoin and Litecoin with a user-rewarding social platform.